UY29776A1 - Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen - Google Patents

Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen

Info

Publication number
UY29776A1
UY29776A1 UY29776A UY29776A UY29776A1 UY 29776 A1 UY29776 A1 UY 29776A1 UY 29776 A UY29776 A UY 29776A UY 29776 A UY29776 A UY 29776A UY 29776 A1 UY29776 A1 UY 29776A1
Authority
UY
Uruguay
Prior art keywords
timoregulating
agomelatin
agent
pharmaceutical compositions
compositions containing
Prior art date
Application number
UY29776A
Other languages
English (en)
Inventor
Christian De Bodinat
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36190792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29776(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY29776A1 publication Critical patent/UY29776A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

NUEVA ASOCIACION ENTRE LA AGOMELATINA Y UN AGENTE TIMOREGULADOR Y COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN.
UY29776A 2005-09-09 2006-08-31 Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen UY29776A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509208A FR2890563B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UY29776A1 true UY29776A1 (es) 2006-11-30

Family

ID=36190792

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29776A UY29776A1 (es) 2005-09-09 2006-08-31 Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen

Country Status (38)

Country Link
US (1) US7902180B2 (es)
EP (2) EP1762238B1 (es)
JP (1) JP2007077149A (es)
KR (2) KR20070029607A (es)
CN (1) CN1927194A (es)
AP (1) AP3045A (es)
AR (1) AR055418A1 (es)
AT (1) ATE519482T1 (es)
AU (1) AU2006209371B2 (es)
BR (1) BRPI0603767A (es)
CA (1) CA2558764C (es)
CY (1) CY1112223T1 (es)
DK (1) DK1762238T3 (es)
EA (1) EA014381B1 (es)
ES (1) ES2371482T3 (es)
FR (1) FR2890563B1 (es)
GE (1) GEP20094741B (es)
GT (1) GT200600410A (es)
HR (1) HRP20110749T1 (es)
JO (1) JO2746B1 (es)
MA (1) MA28504B1 (es)
ME (1) ME01964B (es)
MX (1) MXPA06010234A (es)
MY (1) MY162318A (es)
NO (1) NO338079B1 (es)
NZ (1) NZ549727A (es)
PE (1) PE20070613A1 (es)
PL (1) PL1762238T3 (es)
PT (1) PT1762238E (es)
RS (1) RS52003B (es)
SA (1) SA110320045B1 (es)
SG (1) SG131029A1 (es)
SI (1) SI1762238T1 (es)
TW (1) TWI369980B (es)
UA (1) UA83541C2 (es)
UY (1) UY29776A1 (es)
WO (1) WO2007028903A1 (es)
ZA (1) ZA200607532B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
BR0010151A (pt) * 1999-04-29 2002-06-11 Merck Patent Gmbh Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais
ES2287039T3 (es) * 1999-12-01 2007-12-16 Ucb, S.A. Un derivado de pirrolidinacetamida para el tratamiento de dolor cronico o neuropatico.
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires

Also Published As

Publication number Publication date
CY1112223T1 (el) 2015-12-09
JO2746B1 (en) 2014-03-15
MXPA06010234A (es) 2007-03-08
EP1762238A1 (fr) 2007-03-14
CN1927194A (zh) 2007-03-14
FR2890563A1 (fr) 2007-03-16
ES2371482T3 (es) 2012-01-03
DK1762238T3 (da) 2011-11-07
GEP20094741B (en) 2009-07-27
PT1762238E (pt) 2011-09-01
RS52003B (en) 2012-04-30
NO338079B1 (no) 2016-07-25
NO20064049L (no) 2007-03-12
KR20090056949A (ko) 2009-06-03
EP2301527A1 (fr) 2011-03-30
JP2007077149A (ja) 2007-03-29
AP2008004380A0 (en) 2008-04-30
HRP20110749T1 (hr) 2011-11-30
EP1762238B1 (fr) 2011-08-10
FR2890563B1 (fr) 2007-10-19
US20070066689A1 (en) 2007-03-22
CA2558764A1 (fr) 2007-03-09
TW200800860A (en) 2008-01-01
TWI369980B (en) 2012-08-11
UA83541C2 (uk) 2008-07-25
WO2007028903A1 (fr) 2007-03-15
MY162318A (en) 2017-05-31
MA28504B1 (fr) 2007-04-03
PL1762238T3 (pl) 2011-12-30
ZA200607532B (en) 2008-05-28
NZ549727A (en) 2008-03-28
ME01964B (me) 2012-04-30
ATE519482T1 (de) 2011-08-15
SI1762238T1 (sl) 2011-10-28
GT200600410A (es) 2007-05-21
AU2006209371B2 (en) 2012-02-02
SG131029A1 (en) 2007-04-26
KR20070029607A (ko) 2007-03-14
AU2006209371A1 (en) 2007-03-29
SA110320045B1 (ar) 2014-01-29
BRPI0603767A (pt) 2007-08-14
EA200601450A1 (ru) 2007-04-27
AP3045A (en) 2014-11-30
EA014381B1 (ru) 2010-10-29
PE20070613A1 (es) 2007-07-30
US7902180B2 (en) 2011-03-08
CA2558764C (fr) 2013-01-08
AR055418A1 (es) 2007-08-22

Similar Documents

Publication Publication Date Title
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DOP2019000185A (es) Una formulación sólida de dosificación farmacéutica
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
NO20080023L (no) Magnetoreologisk vaeske
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
UY28348A1 (es) Compuestos novedosos
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
TR200504892A1 (tr) Belirti göstermeyen tüberküloz tedavisi
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
PA8604401A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
BRPI0619911A2 (pt) composto, pró-droga, agente farmacêutico, e, uso do composto
PA8691901A1 (es) Composicion farmaceutica solida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph
AR103567A2 (es) Comprimidos que contienen saborizantes y/o aromatizantes
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
BRPI0608287A2 (pt) agente endoparasiticida
DE60310936D1 (de) Riechstoffzusammensetzung
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
DK1713438T3 (da) Medicinsk sæbe

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180528